课题基金 / 基金详情

项目摘要

项目成果

Ralph V. Shohet的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Hypoxia inducible factor-1 is a principal oxygen sensing molecule in all vertebrates. It is a transcription factor that is regulated by the effect of ambient oxygen concentration on its stability. HIF1 regulates a panoply of genes involved in response to hypoxia, including factors that augment angiogenesis and favor glycolytic metabolism. Nowhere are these responses of greater interest than in the heart, where hypoxia due to coronary artery disease is a major cause of morbidity and mortality in the developed world. We thus seek to determine the effects of HIF1 in the heart, to better understand the endogenous physiological response to hypoxia. We have created a transgenic model where HIF can be expressed in a regulated, cardiac-specific manner. We have generated our transgenic animal with a degradation-resistant HIF1 that is not affected by oxygen concentration. Our underlying hypothesis is that cardiac-specific elevation of HIF1 activity will direct the heart to recapitulate hypoxic responses. Our specific aims test this hypothesis using a combination of molecular, metabolic and physiological techniques. Specific Aim 1: To identify the immediate down-stream targets of HIF1 transcriptional activation in vivo. We will apply comprehensive transcriptional analysis to our model as HIF1 activity increases to catch the first response and identify novel genes that are regulated by HIF1. Specific Aim 2: To measure the contribution of specific biochemical pathways to the HIF1-mediated switch from oxidative to glycolytic metabolism in the heart. This will be accomplished with the magnetic resonance spectroscopy of spin-labeled substrates. Specific Aim 3: To define the angiogenic effects of HIF1 overexpression in the heart. This will require histological and physiological analysis and will be explored in models of hypoxia and infarction.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Training in Cardiovascular Research at the University of Hawaii
  • 批准号:
    9343332
  • 项目类别:
  • 资助金额:
    $2.12万
  • 财政年份:
    2016
  • 负责人:
    Ralph V. Shohet
  • 依托单位:
COBRE III: Center for Cardiovascular Research
  • 批准号:
    8305804
  • 项目类别:
  • 资助金额:
    $91.63万
  • 财政年份:
    2012
  • 负责人:
    Ralph V. Shohet
  • 依托单位:
COBRE III: Center for Cardiovascular Research
  • 批准号:
    8723859
  • 项目类别:
  • 资助金额:
    $108.21万
  • 财政年份:
    2012
  • 负责人:
    Ralph V. Shohet
  • 依托单位:
Training in Cardiovascular Research at the University of Hawaii
  • 批准号:
    10000121
  • 项目类别:
  • 资助金额:
    $38.46万
  • 财政年份:
    2012
  • 负责人:
    Ralph V. Shohet
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: